No image published for this recall
Spiriva capsules ; out-of-specification (uniformity of delivered dose)
Official notice
25 Jun 2026
Last checked
25 Jun 2026
An official Health Canada notice concerns Spiriva capsules ; out-of-specification (uniformity of delivered dose). The affected lot may not consistently provide the intended dose of medication with each use. Published 2026-06-25.
What to do now
Verify if your product is affected.Consult your healthcare provider prior to discontinuing use of the affected product(s), or for any health concerns.Contact the recalling firm if you have any questions about the recall.Report any health product related side effects to Health Canada.Report any other health product safety complaints to Health Canada.
Recall number
82251
Official notice
2026-06-25
The hazard
The hazard
The affected lot may not consistently provide the intended dose of medication with each use.
How to check if you're affected
How to check if you're affected
Compare the VIN on your vehicle against the official list. If your VIN is listed, follow the official notice.
Lots
Other
Recall Numbers
Checked manually this time?
The app watches your VIN and alerts you automatically next time — no searching, no checking back.
Turn on automatic VIN checksAffected products
Affected products
Product 1
Risk / hazard
Where it was sold
Where it was sold
The source does not list specific retailers. See the official notice for where affected vehicles were sold.
Location 1
Affected area 1
Company & contacts
Company & contacts
Brand
Manufacturer
Phone
Brand: Boehringer Ingelheim Canada. Contact: the recalling firm if you have any questions about the recall.
Source & status
Source & status
Source
Tier
Category
Classification
App estimate
Recall details
Recall details
Recall number
Classification
Source tier
Documents, notices & source
See the official notice and source documents for full details.
View full official noticeRelated recalls
Importation of chinese-authorized ifosfamide for injection due to the current shortage of canadian-authorized ifex (ifosfamide for injection)
22 Jun 2026Importation of us-authorized vasopressin injection, usp, 20 units ml (for IV infusion) due to the current shortage of canadian-authorized vasopressin injection, usp, 20 units ml (for im or sc administration)
Importation of portuguese-authorized lentocilin s 1200 1 200 000 iu 4 ml, due to the current shortage of canadian-authorized bicillin l-a 1 200 000 iu 2 ml
Importation of chinese-authorized ifosfamide for injection due to the current shortage of canadian-authorized ifex (ifosfamide for injection)
Weekly recall digest
Get next week's recalls before you need them.
One email every Monday — official-source recalls for your country, and nothing else. Unsubscribe from any email.
The digest is the slow lane — one email a week. For instant, severity-gated alerts the moment a notice is published, get the app.
This recall was published 25 Jun 2026. The next one won't wait for you to search.
RecallScope watches official sources for the brands and VINs you follow, and alerts you the moment a new notice is published.
